Mesothelioma Clinical Trial Information

The following mesothelioma clinical trials information is provided courtesy of the U.S. National Institutes of Health (http://www.nih.gov). All information provided below is dynamically sourced directly from the NIH clinical trials database - this way you can be assured you are viewing the most up-to-date information available.

Cisplatin, Imatinib Mesylate, and Pemetrexed in Malignant Mesothelioma Patients

Cancer Type: Mesothelioma

Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery

Cancer Type: Malignant Mesothelioma

Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers

Cancer Type: Lung Cancer; Mesothelioma

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Cancer Type: Malignant Mesothelioma

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma

Cancer Type: Malignant Mesothelioma

Tomotherapy Treatment for Mesothelioma

Cancer Type: Mesothelioma

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Cancer Type: Malignant Mesothelioma

AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Cancer Type: Malignant Mesothelioma

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

Cancer Type: Malignant Mesothelioma

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Cancer Type: Carcinoma, Non-Small-Cell Lung; Mesothelioma

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Cancer Type: Malignant Mesothelioma

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Cancer Type: Malignant Mesothelioma

Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma

Cancer Type: Esophageal Cancer; Lung Cancer; Malignant Mesothelioma

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

Cancer Type: Malignant Mesothelioma

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Cancer Type: Malignant Mesothelioma

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

Cancer Type: Mesothelioma

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Cancer Type: Mesothelioma

Vorinostat (MK0683, SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma

Cancer Type: Mesothelioma; Lung Cancer

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

Cancer Type: Mesothelioma

Dasatinib in Resectable Malignant Pleural Mesothelioma

Cancer Type: Malignant Pleural Mesothelioma

Dendritic Cell-Based Immunotherapy in Mesothelioma

Cancer Type: Malignant Pleural Mesothelioma

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Cancer Type: Malignant Mesothelioma

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Cancer Type: Mesothelioma

Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma

Cancer Type: Mesothelioma

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Cancer Type: Mesothelioma